CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
103651-09-8 | PLipastatin A 1 (9CI); 12,15-Ethenopyrrolo[2,1-l][1,4,7,10,13,16,19,22]oxaheptaazacyclononacosine,cyclic peptide deriv.; (R)-N-[N-[N2-[1-[N-[N-[N-[N-[N2-[N-(3-Hydroxy-1-oxohexadecyl)-L-a-glutamyl]-D-ornithyl]-L-tyrosyl]-D-allothreonyl]-L-a-glutamyl]-D-alanyl]-L-prolyl]-L-glutaminyl]-D-tyrosyl]-L-isoleucineg1-lactone; L-Isoleucine,N-[N-[N2-[1-[N-[N-[N-[N-[N2-[N-(3-hydroxy-1-oxohexadecyl)-L-a-glutamyl]-D-ornithyl]-L-tyrosyl]-D-allothreonyl]-L-a-glutamyl]-D-alanyl]-L-prolyl]-L-glutaminyl]-D-tyrosyl]-,g1-lactone, (R)-; SNA-60-367-3 | ![]() | C72H110N12O20 | 详情 | 供应商 | |
103955-72-2 | PLipastatin A 2 (9CI); PLipastatinA 1, 1-[N-(3-hydroxy-14-methyl-1-oxohexadecyl)-L-glutamic acid]-, [R-(R*,S*)]-; 12,15-Ethenopyrrolo[2,1-l][1,4,7,10,13,16,19,22]oxaheptaazacyclononacosine,cyclic peptide deriv.; L-Isoleucine,N-[N-[N2-[1-[N-[N-[N-[N-[N2-[N-(3-hydroxy-14-methyl-1-oxohexadecyl)-L-a-glutamyl]-D-ornithyl]-L-tyrosyl]-D-allothreonyl]-L-a-glutamyl]-D-alanyl]-L-prolyl]-L-glutaminyl]-D-tyrosyl]-,g1-lactone, [R-(R*,S*)]-; SNA-60-367-6 | ![]() | C73H112N12O20 | 详情 | 供应商 | |
103955-74-4 | PLipastatin B 2 (9CI); PLipastatinA 1, 1-[N-(3-hydroxy-14-methyl-1-oxohexadecyl)-L-glutamic acid]-6-D-valine-,[R-(R*,S*)]-; 12,15-Ethenopyrrolo[2,1-l][1,4,7,10,13,16,19,22]oxaheptaazacyclononacosine,cyclic peptide deriv.; L-Isoleucine,N-[N-[N2-[1-[N-[N-[N-[N-[N2-[N-(3-hydroxy-14-methyl-1-oxohexadecyl)-L-a-glutamyl]-D-ornithyl]-L-tyrosyl]-D-allothreonyl]-L-a-glutamyl]-D-valyl]-L-prolyl]-L-glutaminyl]-D-tyrosyl]-,g1-lactone, [R-(R*,S*)]-; SNA-60-367-12 | ![]() | C75H116N12O20 | 详情 | 供应商 | |
103955-73-3 | PLipastatin B 1 (9CI); PLipastatinA 1, 6-D-valine-; 12,15-Ethenopyrrolo[2,1-l][1,4,7,10,13,16,19,22]oxaheptaazacyclononacosine,cyclic peptide deriv.; L-Isoleucine,N-[N-[N2-[1-[N-[N-[N-[N-[N2-[N-(3-hydroxy-1-oxohexadecyl)-L-a-glutamyl]-D-ornithyl]-L-tyrosyl]-D-allothreonyl]-L-a-glutamyl]-D-valyl]-L-prolyl]-L-glutaminyl]-D-tyrosyl]-,g1-lactone, (R)- | ![]() | C74H114N12O20 | 详情 | 供应商 |